The study compared the risk of major adverse cardiovascular events (MACE) in people with overweight or obesity and established cardiovascular disease (CVD) but without diabetes, using Wegovy (semaglutide 2.4 mg) versus tirzepatide
New research might add safety tips or reveal new risks, so keeping up to date keeps care safe and smart
Further studies are required to better understand how GGT1, other GGT family members and uncharacterized proteins with GGT activity contribute to extracellular GSH catabolism
Citalopram and Escitalopram are noted for their cardiac considerations, particularly at higher doses, which may influence their use in patients with preexisting heart conditions
National Heart, Lung, and Blood Institute: Coronary Heart Disease Join 50,000+ readers using Doctronic to understand symptoms, medications, and next steps
Common reported effects in clinical use include mild injection site reactions with subcutaneous administration, occasional digestive changes when taken orally, and rare reports of fatigue or dizziness